AG
BIVV

Advisor Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Advisor Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,173
Closed -$118K – 5201
2017
Q4 		$118K Sell
2,173
-100
-4% -$5.47K ﹤0.01% 2445
2017
Q3 		$130K Sell
2,273
-125
-5% -$7.32K ﹤0.01% 2191
2017
Q2 		$144K Sell
2,398
-156
-6% -$8.88K ﹤0.01% 2025
2017
Q1 		$140K Buy
+2,554
New +$126K ﹤0.01% 1925

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Advisor Group's BIVV Position: Q1 2018 in Review

Advisor Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 2,173 shares — an estimated $118K sold.

Advisor Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $144K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Advisor Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Advisor Group sold 2,173 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $118K.
  • Advisor Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Advisor Group's Bioverativ Inc. Common Stock position peaked at $144K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Advisor Group's 13F filing for Q1 2018, filed 15 May 2018.